Learn More
To the Editor: In a recent issue of AIDS, Dr. Walmsley et al analyzed HIV RNA responses to treatment in the tipranavir/ ritonavir and lopinavir/ritonavir (LPV/r) arms of the RESIST trials by baseline(More)
BACKGROUND AND OBJECTIVES Darunavir (DRV, TMC114) is a novel protease inhibitor administered in combination with low-dose ritonavir (DRV/r) and is highly active against both wild-type and(More)